Article

University of Utah researchers highlight deficiencies of current methods of cortical cleanup

San Francisco-Current methods used to evacuate the capsule of lens epithelial cells and other lens material are not sufficient to prevent late complications of Soemmerring's Ring formation, posterior capsule opacification (PCO), and unwanted fibrosis after pediatric cataract surgery, said Brian Zaugg, BS.

San Francisco-Current methods used to evacuate the capsule of lens epithelial cells and other lens material are not sufficient to prevent late complications of Soemmerring’s Ring formation, posterior capsule opacification (PCO), and unwanted fibrosis after pediatric cataract surgery, said Brian Zaugg, BS.

Zaugg reported the findings from a study conducted at the University of Utah, Salt Lake City, using 500 cadaver eyes from the David J. Apple Center databank. The specimens were post-extracapsular cataract extraction and IOL insertion and were examined and photographed using the Miyake-Apple technique. The eyes were evaluated with special reference to identifying PCO and postoperative fibrosis proliferation of lens epithelial cells.

Two levels of intracapsular lens epithelial cell activity were identified through examination of the capsular bag. While 40% of cells were quiescent and appeared no longer capable of causing problematic proliferation, 60% of cells were viable and mitotic. In addition, there were no eyes where complete cortical cleanup was achieved.

The researchers also concluded that a Soemmerring’s Ring occurs in 100% of cases 5 to 7 years after surgery and that all IOL models are susceptible to a breakout of cells from the Soemmerring’s Ring that leads to PCO.

“This study identifies an important problem and even suggests that a paradigm shift needs to be made in the surgical procedure,” Zaugg said. “We recommend that the search for a better means of removing lens material using pharmacologic or other approaches must continue.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.